Asset
Triamcinolone acetonide
Pacira BioSciences Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06977568 | phase2 | terminated | 2025-07-25 | 2025-10-16 | Pacira Pharmaceuticals, Inc | A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip |
| NCT06269705 | phase3 | active_not_recruiting | 2024-02-05 | 2026-12-01 | Pacira Pharmaceuticals, Inc | ZILRETTA in Subjects With Shoulder Osteoarthritis |
FDA applications (1)
| Application | Type | Applicant |
|---|---|---|
| NDA 208845 | NDA | PACIRA PHARMACEUTICALS INC |
Marketed products (1)
- ZILRETTA